DB02555 | SP4160 | experimental | unknown | | Details |
DB02581 | N(2)-carbamimidoyl-N-{2-[4-(3-{4-[(5-carboxyfuran-2-yl)methoxy]-2,3-dichlorophenyl}-1-methyl-1H-pyrazol-5-yl)piperidin-1-yl]-2-oxoethyl}-D-leucinamide | experimental | unknown | | Details |
DB03453 | Methyl (2S)-2-[[2-[(3R)-1-carbamimidoylpiperidin-3-yl]acetyl]amino]-3-[4-(2-phenylethynyl)phenyl]propanoate | experimental | unknown | | Details |
DB03957 | SP2456 | experimental | unknown | | Details |
DB04278 | 2-[2-(2-Cyclohexyl-2-guanidino-acetylamino)-acetylamino]-N-(3-mercapto-propyl)-propionamide | experimental | unknown | | Details |
DB05299 | Keyhole limpet hemocyanin | approved, investigational | unknown | | Details |
DB05304 | Girentuximab | investigational | unknown | | Details |
DB03372 | 3-Mercapto-1-(1,3,4,9-Tetrahydro-B-Carbolin-2-Yl)-Propan-1-One | experimental | unknown | | Details |
DB03455 | (1H-indol-3-yl)-(2-mercapto-ethoxyimino)-acetic acid | experimental | unknown | | Details |
DB00852 | Pseudoephedrine | approved | unknown | inhibitor | Details |
DB01327 | Cefazolin | approved | unknown | inhibitor | Details |
DB06584 | TG4010 | investigational | unknown | | Details |